News

Posted on March 9, 2017

UNINTENDED CONSEQUENCES: IN TREATING CHILDREN WITH CANCER- The Guardian march 9 2017.

Leading doctors are warning that British children with cancer could suffer if they are no longer able to join Europe-wide trials of innovative new medicines as a result of the Brexit deal. The Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust say the best hope for some children with cancer is […] Read More

Posted on March 4, 2017

Hepatitis C “Tour N Cure” In Egypt For $6,200 vs $84,000 in North America:

Come see the Sphinx and save on Sovaldi to treat hepatitis C. That’s the implicit pitch of an unusual campaign that’s spurring dozens of hepatitis C patients to fly to Egypt each month in pursuit of a cure they can afford. The story of the aggressive marketing drive, launched last May as “Tour n’ Cure,” illuminates how […] Read More

Posted on February 26, 2017

MAKING HEALTHCARE DECISIONS ABOUT COMPLEX MATTERS: Raymond Rupert MD, MBA.

Making decisions about healthcare problems is very complex. Patients do not tolerate uncertainty about their health. They can rush to make a decision because it feels better to have reduced uncertainty. This is the need for cognitive closure. With a recent case, the client, who was a senior VP at a large corporation, asked us […] Read More

Posted on February 17, 2017

REHAB IS SO 1970’S: Raymond Rupert MD, MBA.

With substance abuse, the traditional approach has been to enter rehab leaving the real world for 28 or more days. Unfortunately, residential rehab, which is the usual approach to treatment, is known to have very high relapse rates and very high costs. That is why Rupert Case Management (RCM) is delivering transformative experiences for our […] Read More

Posted on February 17, 2017

RELATIONSHIP BETWEEN DECREASED HEALTHCARE FUNDING & INCREASED DEATHS IN THE UK:

An unprecedented rise in mortality in England and Wales, where 30,000 excess deaths occurred in 2015, is likely to be linked to cuts to the NHS and social care, according to research which has drawn an angry response from the government. The highly charged claim is made by researchers from the London School of Hygiene […] Read More

Posted on February 3, 2017

PATIENTS ARE SAFER WITH FOREIGN TRAINED DOCTORS: Source: Stat News by Sharon Begley

  Elderly hospitalized patients treated by doctors who graduated from non-US medical schools are slightly less likely to die within 30 days than those treated by graduates of US medical schools, according to a study published Thursday. About 1 in 4 US physicians were born abroad, and among internists, the primary care doctors who were the focus of the study, […] Read More

Posted on January 22, 2017

SUCCESSFUL SASKATCHEWAN MRI EXPERIMENT IS SHUT DOWN: Raymond Rupert MD, MBA.

Saskatchewan was in the early stages of an experiment involving private-pay health care.  Saskatchewan is where Canadian medicare started. So it is ironic that this is where private healthcare might get its start. Faced with a backlog of people needing MRI scans, and with dwindling provincial resources as a result of a downturn in oil […] Read More

Posted on January 20, 2017

DRUG RATIONING BY THE NHS NOT IN THE PATIENT’S BEST INTERESTS:

A fifth of new drugs will be rationed under tighter NHS cost-cutting plans, meaning that patients will suffer longer delays for medication. Sufferers of cancer, diabetes and asthma could have to queue for treatment as health chiefs are handed powers to restrict access to medicines to save money, even if they have been ruled cost-effective […] Read More

Posted on January 15, 2017

NHS in crisis as cancer operations cancelled due to lack of beds- The Guardian. Jan 15 2017

Patients with cancer are having their operations cancelled by hospitals with increasing regularity as the NHS winter crisis deepens, the Observer can reveal. In an alarming escalation, the previously unthinkable step of calling off cancer surgery has become more commonplace. The revelation will fuel increasingly bitter arguments between the government and NHS staff, both over […] Read More

Posted on January 9, 2017

CAN HEALTHCARE BE GLOBAL? Raymond Rupert

On a recent trip to New York, the food agenda was clearly global. Danish breakfast. French bistro lunch. Italian dining for dinner. Fruit from Chile for snacks. With food, we can take the best of each culinary tradition and move it to our home city. It translates well and leads to a great customer experience. […] Read More

Posted on January 6, 2017

GETTING MOLECULAR PROFILING TESTING DONE FOR CANCER: Raymond Rupert MD, MBA.

Personalized and targeted treatments for cancer are based on the molecular profiling of the cancer’s DNA. Each patient’s cancer can be unique. Once the driver mutations in the cancer’s DNA are recognized by the lab tests, then specific cancer drugs can be prescribed.  These are known as actionable treatment strategies. These new cancer drugs are […] Read More

Posted on December 23, 2016

INCREMENTAL FIXES WON”T TRANSFORM US HEALTHCARE: Raymond Rupert MD, MBA.

Terry Stone in HBR: Incremental Fixes Won’t Save the US Healthcare System December 06, 2016 Terry StoneManaging Partner, Health & Life Sciences, Oliver Wyman @TerryStone92 We need to take bold action to correct our health system’s current trajectory. Incremental shifts, the approach to date, simply won’t address the real challenge confronting the US healthcare system […] Read More

Posted on December 4, 2016

REGIONAL CHEMOTHERAPY AS AN OPTION: Raymond Rupert MD,MBA.

REGIONAL CHEMOTHERAPY AS AN OPTION:   Raymond Rupert MD, MBA. Traditional systemic chemotherapy to treat cancer is delivered using a patient’s veins. Systemic chemotherapy is improving, and will continue to improve, with molecular profiling of cancer DNA (which personalizes the delivery of chemotherapy). However, systemic chemotherapy response rates are low and the chemotherapy makes patients […] Read More

Posted on December 1, 2016

WAIT TIMES FOR SURGERY AT 20 YEAR TIME HIGH IN CANADA: FRASER INSTITUTE

The Globe and Mail  Kelly Grant Published Wednesday, Nov. 23, 2016 5:30AM EST Canadians are waiting longer for surgery and other medical treatments than they have in more than 20 years, according to a right-leaning think tank’s annual survey of specialist physicians across the country. The Fraser Institute’s new tally of health-care queues found the […] Read More

Posted on November 18, 2016

Overall Survival in Many Cancer Drug Trials Provides Marginal Versus Real Improvements:

Sham Mailankody, MB, BS1; Vinay Prasad, MD, MPH2,3 Author Affiliations JAMA Oncol. Published online November 17, 2016. doi:10.1001/jamaoncol.2016.5296 Cancer regulatory approvals aim to permit drugs to be marketed to improve survival or quality of life for patients. Approximately one-third of cancer drugs approved come to market on the basis of demonstrated improvement in overall survival in randomized clinical trials, […] Read More

Posted on November 16, 2016

CRISPR GENE EDITING USED FOR FIRST TIME TO FIGHT LUNG CANCER: Raymond Rupert MD. MBA.

A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at […] Read More

Posted on November 13, 2016

BIG PHARMA AND HIGH COST BIOLOGICS: Raymond Rupert MD, MBA.

Sovaldi is a new biologic produced by Gilead Sciences to treat and cure hepatitis C. The cost for 2 months of treatment with Sovaldi in Egypt is $800. In Canada, Sovaldi costs $55,000. Gilead has a solid hold on the market for hepatitis C with 27 patents for Sovaldi. When analyzed, the patents are base […] Read More

Posted on November 7, 2016

One brain, many genomes : Gilad D. Evrony MD, PhD. Mass General and MIT

While in the laboratory of Christopher Walsh at Boston Children’s Hospital and Harvard Medical School, I became intrigued by reports of neurologic diseases caused by somatic mutations, including rare cases of epilepsy, neurodegeneration, intellectual disability, brain malformations, and autism spectrum disorder (2–8). There were also long-standing hypotheses in the field that somatic genetic diversity may […] Read More

Posted on November 3, 2016

REPAIRING HEARTS WITH PATCHES OF ENGINEERED TISSUE AT U OF PENN: Raymond Rupert MD, MBA.

A patch for a broken heart is an approach to repairing damaged hearts. A heart attack destroys cardiac muscle, resulting in a fibrotic scar. Weinberger et al. created a living patch for injured hearts using endothelial and cardiac cells grown from human induced pluripotent stem cells. These three-dimensional strips were placed over injured areas of […] Read More

Posted on October 28, 2016

EXHAUSTED T CELLS CAN’T DESTROY CANCERS: Raymond Rupert MD, MBA.

What’s the importance of studying T cell exhaustion? These so-called exhausted T cells seem to be one of the main reasons patients can’t get rid of their cancer or clear their infection. T cell exhaustion seems to be a problem not only in natural T cells but also engineered CAR-T cells. Therapeutic CAR-T cells seem to […] Read More

Pages: